-
effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
October 01, 2007 - effect.29–31 No study contained only
stage II patients, and in the study with the most stage II
patients … affected the surgery choices for both stage I and stage
II patients, whereas the local area BCSI rate … affected only the
surgery choices for stage II patients and did not affect the
surgery choices for stage … linear probability model and the IV estimates
using combined stage I and stage II patients are consistently … Patient Groups
Per Instrument
ESBC Patients
All
(N � 6185)
Stage I
(N � 3280)
Stage II
(N � 2905
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colon-cancer-gene-profiling_disposition-comments.pdf
December 14, 2012 - Technical Brief Disposition of Comments Report for Gene Expression Profiling for Predicting Outcomes in Stage … Gene Expression Profiling for
Predicting Outcomes in Stage II Colon Cancer. Technical Brief. … (and stage subgroups)
separates patients into prognostic subsets. … Nitsche reported that ColoPrint identified most stage II
patients (73%) as low risk. … Tabernero reported “ColoPrint
classifies two-thirds of the stage II patients as Low Risk.
-
effectivehealthcare.ahrq.gov/products/colorectal-cancer/abstract
April 14, 2010 - Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age … Comparative effectiveness of oxaliplatin vs non-oxaliplatin-containing adjuvant chemotherapy for stage … Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage … of adverse events during 5-fluorouracil versus 5-fluorouracil/oxaliplatin adjuvant chemotherapy for stage
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ocd-draft-report-kq2-appendix.xlsx
January 01, 2023 - ES 95% CI SE P-Value Favors Strength
25721185 Torp 2015 GPA NordLOTS, stage 1 14 weeks (post-treatment … Gender NR B 0.35 -1.79 to 2.49 0.75 NS Neutral (Nonsignificant)
25721185 Torp 2015 GPA NordLOTS, stage … 0.86 0.04 7-11 Strength unclear (Continuous predictors; P<0.05)
25721185 Torp 2015 GPA NordLOTS, stage … ≥22 vs <22 B 0.06 -0.01 to 0.13 0.83 NS Neutral (Nonsignificant)
25721185 Torp 2015 GPA NordLOTS, stage … Yes vs no B 1.18 -1.33 to 3.69 0.356 NS Neutral (Nonsignificant)
25721185 Torp 2015 GPA NordLOTS, stage
-
effectivehealthcare.ahrq.gov/products/renal-disease-therapies
March 31, 2011 - Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-Stage … Comparative Effectiveness of Antihypertensive Therapies on Cardiovascular Disease Outcomes In End-Stage
-
effectivehealthcare.ahrq.gov/products/renal-disease-iron
January 24, 2012 - Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage Renal … Comparative Effectiveness of Intravenous Iron Formulations in the Treatment of Anemia in End Stage
-
effectivehealthcare.ahrq.gov/products/renal-disease-anemia
March 31, 2011 - Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in End-Stage … Comparative Effectiveness Research to Improve Anemia Management and Cardiovascular Disease Outcomes in End-Stage
-
effectivehealthcare.ahrq.gov/products/chronic-kidney-disease-anemia
January 14, 2013 - Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage Chronic Kidney Disease: Future … Review
Archived
Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage
-
effectivehealthcare.ahrq.gov/products/kidney-disease-medicine/research-protocol
July 28, 2010 - Within this framework, K/DOQI then classified CKD into five stages as follows:
Stage 1: Kidney damage … with GFR >90 mL/min/1.73 m 2
Stage 2: Kidney damage with GFR 60-89 mL/min/1.73 m 2
Stage 3: GFR … 30-59 mL/min/1.73 m 2
Stage 4: GFR 15-29 mL/min/1.73 m 2
Stage 5: GFR <15 mL/min/1.73 m 2 or kidney … (2) Albuminuria stages should be added within each GFR stage (urinary ACR <30 mg/g, 30-299 mg/g, or … stage 2 CKD, 7.7% (15.5 million) in stage 3 CKD, and 0.4% (0.7 million) in stage 4 CKD. 3 U.S. prevalence
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/kidney-disease-medicine_research-protocol.pdf
November 01, 2010 - 2: Kidney damage with GFR 60-89 mL/min/1.73 m2
• Stage 3: GFR 30-59 mL/min/1.73 m2
• Stage 4: GFR … (2) Albuminuria stages should be added within each GFR stage (urinary ACR <30 mg/g,
30-299 mg/g … Epidemiology of CKD
Based on the K/DOQI CKD definition and stage classification, and utilizing a … Of the population,1.8% (3.6
million) individuals were classified in stage 1 CKD, 3.2% (6.5 million) … in stage 2 CKD,
7.7% (15.5 million) in stage 3 CKD, and 0.4% (0.7 million) in stage 4 CKD.3 U.S.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_executive.pdf
June 01, 2013 - 1
Comparative Effectiveness Review
Number 112
Local Nonsurgical Therapies for Stage I
and Symptomatic … I, stage II,
and selected stage III tumors)
• Potentially operable or inoperable locally (T3–T4) … Several radiotherapy
modalities have been used to treat patients with
stage I NSCLC. … Surgery is the standard of care for eligible patients with
stage I NSCLC. … The treatment of early-stage disease.
Semin Radiat Oncol. 2010 Jul;20(3):178-85.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/lung-cancer-nonsurgical-therapies_disposition-comments.pdf
June 12, 2013 - Disposition of Comments for Local Nonsurgical Therapies for Stage I and Symptomatic Obstructive Non-Small-Cell … The CER is about local, nonsurgical interventions for
stage I NSCLC. … There is a lack of analysis for RFA of
medically inoperable stage I NSCLC. … Stereotactic body
radiation therapy for inoperable early stage lung cancer. … , not “local
therapies for stage I” lung cancer as stated.
-
effectivehealthcare.ahrq.gov/products/colorectal-cancer-staging/research
September 10, 2014 - Treatment options for colorectal cancer differ depending on the clinical stage of disease at diagnosis … cancer T (tumor) staging, ERUS is more accurate than CT; ERUS is less likely than CT to incorrectly stage … MRI was less likely to overstage preoperative rectal cancer N stage than CT (OR = 0.498; 95% CI, 0.308
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-staging_disposition-comments.pdf
November 20, 2014 - This is an understatement since the
standard of care for stage II and III rectal cancer is neoadjuvant … Table A: The table shows specificity of T1 stage as 75.8. … For preoperative rectal cancer T (tumor) staging, ERUS is less
likely than CT to incorrectly stage ( … Specifically, most of the analyses on T-stage did
not distinguish the strengths of ultrasound vs MRI … late T-stage extent.
-
effectivehealthcare.ahrq.gov/health-topics/anemia-0
April 25, 2013 - Archived
June 16, 2010
Biomarkers for Assessing and Managing Iron Deficiency Anemia in Late-Stage
-
effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_2.pdf
May 01, 2020 - of labor (low SOE) or
duration of the second stage of labor (low SOE). … The natural
history of the normal first stage of labor. … Effects of
LI4 acupressure on labor pain in the first stage of labor. … Upright
position during the first stage of labor: a randomised
controlled trial. … Maternal
positions and mobility during first stage labour.
-
effectivehealthcare.ahrq.gov/products/colorectal-cancer-staging/research-protocol
May 21, 2013 - However, stage is the key determinant of the management strategy. … that is compared against the stage established by the reference standard. … Stage reclassification or clinical decision impact . … Stage reclassification . … The change in stage of the cancer after imaging, compared with the stage determined based on information
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points_1_diabetic-foot-ulcers_data_02-2011.pdf
January 01, 2011 - Diabetes
Diabetes Rate
in Enrolled
Population
Total All 2006 32.8 8.7 26.4%
Age
Disabled/end stage … American
Indian/Alaska Native
2006 0.1 0.1 36.0%
Total All 2007 32.3 8.8 27.3%
Age Disabled/end stage … American
Indian/Alaska Native
2007 0.2 0.1 37.3%
Total All 2008 31.9 8.9 27.9%
Age Disabled/end stage … Beneficiaries
With Diabetes and
Without PAD
Total All 2006 8.1% 19.2% 5.0%
Age Disabled/end stage … Beneficiaries With
Diabetes and Without
PAD
Total All 2006 1.8% 6.5% 0.6%
Age Disabled/end stage
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-testing-machine-learning-tool-chronic-pain.pdf
November 01, 2020 - (Stage 3). … on monthly update searches (Stage 3). … Stage 2: Test Machine Learning Classifier on Optimized
Searches
In Stage 2, we aimed to develop machine … Background
Methods
Stage 1: Develop Optimized Search Strategies
Stage 2: Test Machine Learning Classifier … Search Strategies
Stage 2: Test Machine Learning Classifier on Optimized Searches
Stage 3: Test Machine
-
effectivehealthcare.ahrq.gov/sites/default/files/data-points_2_diabetic-foot-ulcers_data_02-2011.pdf
January 01, 2011 - Enrolled Beneficiaries
With Diabetes and
Without PAD
Total All 2006 6.0% 13.5% 4.0%
Age Disabled/end stage … Beneficiaries
With Diabetes and
Without PAD
Total All 2006 0.5% 2.1% 0.053%
Age Disabled/end stage … Indian/Alaska
Native
2006 1.0% 5.6% 0.135%
Total All 2007 0.5% 1.9% 0.055%
Age Disabled/end stage … Indian/Alaska
Native
2007 0.8% 4.7% 0.131%
Total All 2008 0.4% 1.8% 0.058%
Age Disabled/end stage … Enrolled Diabetic Population
Q1 Q2 Q3 Q4
Total All 2006 1.76% 1.81% 1.68% 1.47%
Age Disabled/end stage